Search

Your search keyword '"Godley, Lucy"' showing total 420 results

Search Constraints

Start Over You searched for: Author "Godley, Lucy" Remove constraint Author: "Godley, Lucy" Journal blood Remove constraint Journal: blood
420 results on '"Godley, Lucy"'

Search Results

1. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

3. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms

4. Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

5. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

6. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

8. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations

9. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

10. ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

13. Increased DNA methylation of Dnmt3b targets impairs leukemogenesis

14. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia

16. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

17. Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies

18. Molecular Characterization of Adult Acute Lymphoblastic Leukemia Identifies a Subgroup with Myeloid Mutations and Pre-Existing Clonal Hematopoiesis

19. Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2 and DDX41

20. Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies

23. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation

24. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

25. Deleterious Germline Variants Are Present in Patients with Myelodysplastic Syndrome of All Ages Treated with Related Allogeneic Stem Cell Transplantation

28. Interplay between Inflammatory Microenvironment and RUNX1-Mediated Transcriptomic Changes Drives Defective Hematopoiesis in Familial Platelet Disorder

30. Germ line DDX41mutations define a unique subtype of myeloid neoplasms

32. Assessing the Feasibility and Limitations of Cultured Skin Fibroblasts for Germline Genetic Testing in Hematologic Disorders

33. Expanding Use of a Modified Pediatric Intensive Regimen for Acute Lymphoblastic Leukemia (ALL) into an Older Adult Population: Feasibility and Efficacy Results

35. Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2and DDX41

36. Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological Malignancy

37. Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS

40. Germline Risks and Clinical Impacts of DDX41Mutations in Myeloid Malignancies

41. Myeloid Malignancy Variant Curation Expert Panel: An ASH-Sponsored Clingen Expert Panel to Optimize and Validate Acmg/AMP Variant Interpretation Guidelines for Genes Associated with Inherited Myeloid Neoplasms

42. Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)

43. Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB

45. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

49. Comorbidity from Solid Tumor or Hematologic Malignancy Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) May Both Increase Non-Relapse Mortality

50. Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable

Catalog

Books, media, physical & digital resources